Quantcast
Channel: Comments for Scholarly Open Access
Viewing all articles
Browse latest Browse all 10802

Comment on Another Fleet Startup: JSciMed Central by Joseph Tariman

0
0

This company JSciMedcentral is likely a fraudulent company. I was invited to serve as “special issue editor” and I receive a paper from a Dr. Ota Fuchs from Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic. The abstract says myeloma is a primary bone malignancy, which every hematologist knows is a wrong statement. Myeloma is a hematologic malignacy; not a primary bone malignancy. There were 9 figures related to proteasome inhibition and they were beautifully crafted but no citation of sources; a clear example of plagiarism. I believe this paper was not written by Dr. Ota Fuchs. It was fabricated by JScimedCentral.
When I submitted the whole special issue on myeloma containing an editorial, a case report, 2 review papers and an original research paper, I did not get any reply from Christine Abraham, editorial assistant with a contact info as follows:
2952 Market Street, Suite 140
San Diego, California 92102, USA
Tel: 1-302-360-8046
Fax: 1-302-360-8174
Toll free number: 1-800-762-9856
E-mail: hematology@jscimedcentral.com

I did Google earth and found that this physical address is a a house in a shoddy neighborhood/warehouse area in San Diego.

DO NOT give your credit card number via email to this company to pay for open access of your manuscript. When you call the number provided, you will only get a robotic voice mail messages. I called this number 5 times during office hours Pacific time and never got a real person. A clear Red Flag.


Viewing all articles
Browse latest Browse all 10802

Latest Images

Trending Articles





Latest Images